X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1599) 1599
Publication (157) 157
Book / eBook (52) 52
Book Review (29) 29
Book Chapter (24) 24
Newspaper Article (20) 20
Magazine Article (8) 8
Dissertation (2) 2
Conference Proceeding (1) 1
Newsletter (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1334) 1334
male (886) 886
sleep wake disorders - chemically induced (861) 861
female (780) 780
index medicus (561) 561
adult (549) 549
sleep (535) 535
middle aged (500) 500
animals (333) 333
aged (304) 304
neurosciences (298) 298
psychiatry (285) 285
clinical neurology (244) 244
sleep - drug effects (216) 216
sleep disorders (207) 207
pharmacology & pharmacy (191) 191
insomnia (164) 164
adolescent (162) 162
rats (156) 156
sleep - physiology (142) 142
sleep wake disorders - drug therapy (141) 141
treatment outcome (137) 137
child (123) 123
double-blind method (123) 123
time factors (123) 123
analysis (113) 113
dose-response relationship, drug (111) 111
depression (110) 110
neurology (110) 110
risk factors (109) 109
sleep wake disorders - physiopathology (106) 106
polysomnography (102) 102
electroencephalography (100) 100
double-blind (97) 97
research (95) 95
surveys and questionnaires (87) 87
mice (85) 85
article (82) 82
physiology (80) 80
sleep initiation and maintenance disorders - chemically induced (79) 79
clinical trials as topic (78) 78
young adult (78) 78
care and treatment (77) 77
headache - chemically induced (77) 77
sleep, rem - drug effects (77) 77
sleep stages - drug effects (76) 76
health aspects (75) 75
brain (74) 74
hypnotics and sedatives - adverse effects (74) 74
sleep wake disorders - etiology (72) 72
disease models, animal (70) 70
fatigue - chemically induced (70) 70
sleep wake disorders - diagnosis (70) 70
wakefulness - drug effects (70) 70
medicine, general & internal (69) 69
sleep wake disorders - epidemiology (69) 69
drug therapy (68) 68
prevalence (68) 68
rem-sleep (68) 68
medicine & public health (67) 67
physiological aspects (67) 67
parkinson disease - drug therapy (66) 66
aged, 80 and over (65) 65
child, preschool (65) 65
depression - chemically induced (64) 64
circadian rhythm (62) 62
drug administration schedule (62) 62
quality of life (62) 62
nausea - chemically induced (61) 61
sleep deprivation (61) 61
wakefulness (61) 61
children (60) 60
drug therapy, combination (59) 59
hypnotics and sedatives - therapeutic use (59) 59
neurons (58) 58
placebos (58) 58
sleep wake disorders - psychology (58) 58
fatigue (57) 57
anticonvulsants - adverse effects (56) 56
sleep initiation and maintenance disorders - drug therapy (56) 56
antipsychotic agents - adverse effects (55) 55
melatonin (55) 55
pediatrics (55) 55
therapy (55) 55
narcolepsy (54) 54
severity of illness index (54) 54
efficacy (52) 52
prospective studies (52) 52
cancer (51) 51
drugs (51) 51
rats, sprague-dawley (51) 51
sleep wake disorders - complications (50) 50
disorders (49) 49
behavior (48) 48
cognition disorders - chemically induced (48) 48
depressive disorder - drug therapy (48) 48
psychology, clinical (48) 48
age factors (47) 47
antidepressive agents - adverse effects (47) 47
eeg (47) 47
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
UofT at Mississauga - Stacks (11) 11
Robarts - Stacks (10) 10
UofT at Scarborough - Stacks (9) 9
OISE - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UTL at Downsview - May be requested (3) 3
Gerstein Science - Reference (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
OISE - Reference (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
St. Michael's Hospital - Stacks (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Online (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
St. Augustine's Seminary - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Missing (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1506) 1506
German (52) 52
French (40) 40
Russian (24) 24
Italian (23) 23
Spanish (16) 16
Japanese (13) 13
Czech (6) 6
Polish (6) 6
Danish (4) 4
Norwegian (3) 3
Chinese (2) 2
Dutch (2) 2
Romanian (2) 2
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
Abstract Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins are well tolerated, but associated with various statin-associated... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
Journal of Child Psychology and Psychiatry, ISSN 0021-9630, 03/2013, Volume 54, Issue 3, pp. 227 - 246
Background:  Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well‐tolerated, there are common,... 
ADHD | medication | adverse events | European | management | recommendations | SUBSTANCE USE DISORDERS | SLEEP | SUDDEN-DEATH | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | SERIOUS CARDIOVASCULAR EVENTS | FOLLOW-UP | DEFICIT-HYPERACTIVITY DISORDER | PSYCHOLOGY | STIMULANT MEDICATIONS | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | PEDIATRIC-PATIENTS | OROS METHYLPHENIDATE | Therapy | Behavior Disorders | Europe | Drug Therapy | Risk | Foreign Countries | Suicide | Substance Abuse | Patients | Scientific Research | Incidence | Guidelines | Physical Development | Outcomes of Treatment | Sleep | Attention Deficit Hyperactivity Disorder | Literature Reviews | Meta Analysis | Symptoms (Individual Disorders) | Eating Habits | Seizures | Sleep Wake Disorders - chemically induced | Tic Disorders - therapy | Cardiovascular Diseases - prevention & control | Humans | Suicide - prevention & control | Dextroamphetamine - adverse effects | Seizures - chemically induced | Heart Rate - drug effects | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Guanfacine - adverse effects | Atomoxetine Hydrochloride | Blood Pressure - drug effects | Child | Methylphenidate - administration & dosage | Substance-Related Disorders - etiology | Growth Disorders - chemically induced | Body Size - drug effects | Psychoses, Substance-Induced | Sleep Wake Disorders - therapy | Clonidine - adverse effects | Treatment Outcome | Methylphenidate - adverse effects | Seizures - therapy | Substance-Related Disorders - therapy | Attention Deficit Disorder with Hyperactivity - drug therapy | Propylamines - administration & dosage | Adolescent | Tic Disorders - chemically induced | Cardiovascular Diseases - chemically induced | Propylamines - adverse effects | Attention deficit disorder | Side effects | Drug therapy | Children & youth | Best practice
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2010, Volume 65, Issue 2, pp. 320 - 327
Journal Article
Urology, ISSN 0090-4295, 10/2018, Volume 120, pp. 143 - 149
Journal Article